{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T10:55:20Z","timestamp":1791456920708,"version":"4.3.4"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2021,8,30]],"date-time":"2021-08-30T00:00:00Z","timestamp":1630281600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2021,8,30]],"date-time":"2021-08-30T00:00:00Z","timestamp":1630281600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/100008322","name":"csl behring","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008322","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dermatol Ther (Heidelb)"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1007\/s13555-021-00593-x","type":"journal-article","created":{"date-parts":[[2021,8,30]],"date-time":"2021-08-30T09:03:56Z","timestamp":1630314236000},"page":"1829-1838","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Recognition and Management of Hereditary Angioedema: Best Practices for Dermatologists"],"prefix":"10.1007","volume":"11","author":[{"given":"Michael E.","family":"Manning","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,8,30]]},"reference":[{"issue":"8","key":"593_CR1","doi-asserted-by":"publisher","first-page":"1575","DOI":"10.1111\/all.13384","volume":"73","author":"M Maurer","year":"2018","unstructured":"Maurer M, Magerl M, Ansotegui I, et\u00a0al. The international WAO\/EAACI guideline for the management of hereditary angioedema\u2014the 2017 revision and update. Allergy. 2018;73(8):1575\u201396.","journal-title":"Allergy"},{"issue":"3","key":"593_CR2","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1016\/j.jaci.2012.05.055","volume":"130","author":"K Bork","year":"2012","unstructured":"Bork K, Hardt J, Witzke G. Fatal laryngeal attacks and mortality in hereditary angioedema due to C1-INH deficiency. J Allergy Clin Immunol. 2012;130(3):692\u20137.","journal-title":"J Allergy Clin Immunol"},{"issue":"12","key":"593_CR3","first-page":"1443","volume":"16","author":"J Hahn","year":"2018","unstructured":"Hahn J, Hoess A, Friedrich DT, et\u00a0al. Unnecessary abdominal interventions in patients with hereditary angioedema. J Dtsch Dermatol Ges. 2018;16(12):1443\u20139.","journal-title":"J Dtsch Dermatol Ges"},{"issue":"4","key":"593_CR4","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1016\/j.anai.2016.08.014","volume":"117","author":"A Zanichelli","year":"2016","unstructured":"Zanichelli A, Longhurst HJ, Maurer M, et\u00a0al. Misdiagnosis trends in patients with hereditary angioedema from the real-world clinical setting. Ann Allergy Asthma Immunol. 2016;117(4):394\u20138.","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"1","key":"593_CR5","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.jaip.2020.08.046","volume":"9","author":"PJ Busse","year":"2021","unstructured":"Busse PJ, Christiansen SC, Riedl MA, et\u00a0al. US HAEA Medical Advisory Board 2020 guidelines for the management of hereditary angioedema. J Allergy Clin Immunol Pract. 2021;9(1):132-50.e3.","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"1","key":"593_CR6","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/0091-6749(83)90052-0","volume":"72","author":"T Fields","year":"1983","unstructured":"Fields T, Ghebrehiwet B, Kaplan AP. Kinin formation in hereditary angioedema plasma: evidence against kinin derivation from C2 and in support of \u201cspontaneous\u201d formation of bradykinin. J Allergy Clin Immunol. 1983;72(1):54\u201360.","journal-title":"J Allergy Clin Immunol"},{"issue":"3","key":"593_CR7","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.anai.2010.01.007","volume":"104","author":"AP Kaplan","year":"2010","unstructured":"Kaplan AP, Joseph K. The bradykinin-forming cascade and its role in hereditary angioedema. Ann Allergy Asthma Immunol. 2010;104(3):193\u2013204.","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"1","key":"593_CR8","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/s12245-017-0141-z","volume":"10","author":"JA Bernstein","year":"2017","unstructured":"Bernstein JA, Cremonesi P, Hoffmann TK, Hollingsworth J. Angioedema in the emergency department: a practical guide to differential diagnosis and management. Int J Emerg Med. 2017;10(1):15.","journal-title":"Int J Emerg Med"},{"issue":"1","key":"593_CR9","doi-asserted-by":"publisher","first-page":"3","DOI":"10.2500\/aap.2013.34.3623","volume":"34","author":"JA Bernstein","year":"2013","unstructured":"Bernstein JA. HAE update: epidemiology and burden of disease. Allergy Asthma Proc. 2013;34(1):3\u20136.","journal-title":"Allergy Asthma Proc"},{"issue":"1","key":"593_CR10","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1186\/s13023-020-01570-x","volume":"15","author":"K Bork","year":"2020","unstructured":"Bork K, Machnig T, Wulff K, Witzke G, Prusty S, Hardt J. Clinical features of genetically characterized types of hereditary angioedema with normal C1 inhibitor: a systematic review of qualitative evidence. Orphanet J Rare Dis. 2020;15(1):289.","journal-title":"Orphanet J Rare Dis"},{"issue":"2","key":"593_CR11","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1007\/s12016-016-8561-8","volume":"51","author":"BL Zuraw","year":"2016","unstructured":"Zuraw BL, Christiansen SC. HAE pathophysiology and underlying mechanisms. Clin Rev Allergy Immunol. 2016;51(2):216\u201329.","journal-title":"Clin Rev Allergy Immunol"},{"issue":"1","key":"593_CR12","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1007\/s12016-021-08841-w","volume":"61","author":"M Maurer","year":"2021","unstructured":"Maurer M, Magerl M. Differences and similarities in the mechanisms and clinical expression of bradykinin-mediated vs mast cell-mediated angioedema. Clin Rev Allergy Immunol. 2021;61(1):40\u20139.","journal-title":"Clin Rev Allergy Immunol"},{"issue":"12","key":"593_CR13","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.1056\/NEJMra1808012","volume":"382","author":"PJ Busse","year":"2020","unstructured":"Busse PJ, Christiansen SC. Hereditary angioedema. N Engl J Med. 2020;382(12):1136\u201348.","journal-title":"N Engl J Med"},{"issue":"4","key":"593_CR14","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1159\/000500196","volume":"235","author":"A Bygum","year":"2019","unstructured":"Bygum A. Hereditary angio-oedema for dermatologists. Dermatology. 2019;235(4):263\u201375.","journal-title":"Dermatology"},{"issue":"2","key":"593_CR15","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.anai.2012.11.014","volume":"110","author":"SA Tilles","year":"2013","unstructured":"Tilles SA, Borish L, Cohen JP. Management of hereditary angioedema in 2012: scientific and pharmacoeconomic perspectives. Ann Allergy Asthma Immunol. 2013;110(2):70\u20134.","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"6","key":"593_CR16","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1111\/bjh.14059","volume":"173","author":"BL Zuraw","year":"2016","unstructured":"Zuraw BL, Christiansen SC. How we manage persons with hereditary angioedema. Br J Haematol. 2016;173(6):831\u201343.","journal-title":"Br J Haematol"},{"issue":"2","key":"593_CR17","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1136\/jcp.2003.12021","volume":"57","author":"Y Karim","year":"2004","unstructured":"Karim Y, Griffiths H, Deacock S. Normal complement C4 values do not exclude hereditary angioedema. J Clin Pathol. 2004;57(2):213\u20134.","journal-title":"J Clin Pathol"},{"issue":"20","key":"593_CR18","doi-asserted-by":"publisher","first-page":"2417","DOI":"10.1001\/archinte.161.20.2417","volume":"161","author":"UC Nzeako","year":"2001","unstructured":"Nzeako UC, Frigas E, Tremaine WJ. Hereditary angioedema: a broad review for clinicians. Arch Intern Med. 2001;161(20):2417\u201329.","journal-title":"Arch Intern Med"},{"key":"593_CR19","unstructured":"KALBITOR\u00ae [package insert]. Lexington, MA: Dyax Corp., a Takeda Company; 2020."},{"issue":"5","key":"593_CR20","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1016\/S1081-1206(10)60506-6","volume":"102","author":"T Craig","year":"2009","unstructured":"Craig T, Riedl M, Dykewicz MS, et\u00a0al. When is prophylaxis for hereditary angioedema necessary? Ann Allergy Asthma Immunol. 2009;102(5):366\u201372.","journal-title":"Ann Allergy Asthma Immunol"},{"key":"593_CR21","unstructured":"CINRYZE\u00ae [package insert]. Lexington, MA: Shire ViroPharma, Inc.; 2018."},{"issue":"6","key":"593_CR22","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1056\/NEJMoa0805538","volume":"363","author":"BL Zuraw","year":"2010","unstructured":"Zuraw BL, Busse PJ, White M, et\u00a0al. Nanofiltered C1 inhibitor concentrate for treatment of hereditary angioedema. N Engl J Med. 2010;363(6):513\u201322.","journal-title":"N Engl J Med"},{"issue":"5","key":"593_CR23","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1016\/j.jaip.2013.07.002","volume":"1","author":"BL Zuraw","year":"2013","unstructured":"Zuraw BL, Banerji A, Bernstein JA, et\u00a0al. US Hereditary Angioedema Association Medical Advisory Board 2013 recommendations for the management of hereditary angioedema due to C1 inhibitor deficiency. J Allergy Clin Immunol Pract. 2013;1(5):458\u201367.","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"5","key":"593_CR24","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1016\/j.jaip.2013.04.003","volume":"1","author":"SM Yoo","year":"2013","unstructured":"Yoo SM, Khan DA. Implantable venous access device associated complications in patients with hereditary angioedema. J Allergy Clin Immunol Pract. 2013;1(5):524\u20135.","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"1","key":"593_CR25","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.anai.2017.05.017","volume":"119","author":"MA Riedl","year":"2017","unstructured":"Riedl MA, Banerji A, Busse PJ, et\u00a0al. Patient satisfaction and experience with intravenously administered C1-inhibitor concentrates in the United States. Ann Allergy Asthma Immunol. 2017;119(1):59\u201364.","journal-title":"Ann Allergy Asthma Immunol"},{"key":"593_CR26","unstructured":"HAEGARDA\u00ae [package insert]. Kankakee, IL: CSL Behring, LLC; 2020."},{"issue":"3","key":"593_CR27","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1159\/000467830","volume":"1","author":"PJ Sp\u00e4th","year":"1984","unstructured":"Sp\u00e4th PJ, W\u00fcthrich B, B\u00fctler R. Quantification of C1-inhibitor functional activities by immunodiffusion assay in plasma of patients with hereditary angioedema\u2013evidence of a functionally critical level of C1-inhibitor concentration. Complement. 1984;1(3):147\u201359.","journal-title":"Complement"},{"issue":"10","key":"593_CR28","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1111\/all.12658","volume":"70","author":"BL Zuraw","year":"2015","unstructured":"Zuraw BL, Cicardi M, Longhurst HJ, et\u00a0al. Phase II study results of a replacement therapy for hereditary angioedema with subcutaneous C1-inhibitor concentrate. Allergy. 2015;70(10):1319\u201328.","journal-title":"Allergy"},{"issue":"12","key":"593_CR29","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1056\/NEJMoa1613627","volume":"376","author":"H Longhurst","year":"2017","unstructured":"Longhurst H, Cicardi M, Craig T, COMPACT Investigators, et\u00a0al. Prevention of hereditary angioedema attacks with a subcutaneous C1 inhibitor. N Engl J Med. 2017;376(12):1131\u201340.","journal-title":"N Engl J Med"},{"issue":"6","key":"593_CR30","doi-asserted-by":"publisher","first-page":"1793","DOI":"10.1016\/j.jaip.2019.01.054","volume":"7","author":"T Craig","year":"2019","unstructured":"Craig T, Zuraw B, Longhurst H, COMPACT Investigators, et\u00a0al. Long-term outcomes with subcutaneous C1-inhibitor replacement therapy for prevention of hereditary angioedema attacks. J Allergy Clin Immunol Pract. 2019;7(6):1793-802.e2.","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"6","key":"593_CR31","doi-asserted-by":"publisher","first-page":"2035","DOI":"10.1016\/j.jaip.2019.01.007","volume":"7","author":"T Craig","year":"2019","unstructured":"Craig T, Lumry W, Cicardi M, et\u00a0al. Treatment effect of switching from intravenous to subcutaneous C1-inhibitor for prevention of hereditary angioedema attacks: COMPACT subgroup findings. J Allergy Clin Immunol Pract. 2019;7(6):2035\u20138.","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"8","key":"593_CR32","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1056\/NEJMoa1605767","volume":"376","author":"A Banerji","year":"2017","unstructured":"Banerji A, Busse P, Shennak M, et\u00a0al. Inhibiting plasma kallikrein for hereditary angioedema prophylaxis. N Engl J Med. 2017;376(8):717\u201328.","journal-title":"N Engl J Med"},{"key":"593_CR33","unstructured":"TAKHZYROTM [package insert]. Lexington, MA: Dyax Corp; 2018."},{"issue":"20","key":"593_CR34","doi-asserted-by":"publisher","first-page":"2108","DOI":"10.1001\/jama.2018.16773","volume":"320","author":"A Banerji","year":"2018","unstructured":"Banerji A, Riedl MA, Bernstein JA, et\u00a0al. Effect of lanadelumab compared with placebo on prevention of hereditary angioedema attacks: a randomized clinical trial [published correction appears in JAMA. 2019;321(16):1636]. JAMA. 2018;320(20):2108\u201321.","journal-title":"JAMA"},{"key":"593_CR35","doi-asserted-by":"publisher","DOI":"10.1111\/all.15011","author":"A Banerji","year":"2021","unstructured":"Banerji A, Bernstein JA, Johnston DT, et al. Long-term prevention of hereditary angioedema attacks with lanadelumab: the HELP OLE Study. Allergy. 2021. https:\/\/doi.org\/10.1111\/all.15011.","journal-title":"Allergy."},{"key":"593_CR36","unstructured":"ORLADEYOTM [package insert]. Durham, NC: BioCryst Pharmaceuticals, Inc.; 2020."},{"issue":"1","key":"593_CR37","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/j.jaci.2020.10.015","volume":"148","author":"B Zuraw","year":"2021","unstructured":"Zuraw B, Lumry WR, Johnston DT, et\u00a0al. Oral once-daily berotralstat for the prevention of hereditary angioedema attacks: a randomized, double-blind, placebo-controlled phase 3 trial. J Allergy Clin Immunol. 2021;148(1):164-72.e9.","journal-title":"J Allergy Clin Immunol"},{"issue":"4","key":"593_CR38","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.anai.2015.01.003","volume":"114","author":"MA Riedl","year":"2015","unstructured":"Riedl MA. Critical appraisal of androgen use in hereditary angioedema: a systematic review. Ann Allergy Asthma Immunol. 2015;114(4):281-8.e7.","journal-title":"Ann Allergy Asthma Immunol"},{"key":"593_CR39","doi-asserted-by":"publisher","first-page":"839","DOI":"10.2147\/IJWH.S46460","volume":"6","author":"T Caballero","year":"2014","unstructured":"Caballero T, Canabal J, Rivero-Paparoni D, Caba\u00f1as R. Management of hereditary angioedema in pregnant women: a review. Int J Womens Health. 2014;6:839\u201348.","journal-title":"Int J Womens Health"}],"container-title":["Dermatology and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13555-021-00593-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13555-021-00593-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13555-021-00593-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,30]],"date-time":"2021-09-30T18:02:30Z","timestamp":1633024950000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13555-021-00593-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,30]]},"references-count":39,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021,10]]}},"alternative-id":["593"],"URL":"https:\/\/doi.org\/10.1007\/s13555-021-00593-x","relation":{},"ISSN":["2193-8210","2190-9172"],"issn-type":[{"value":"2193-8210","type":"print"},{"value":"2190-9172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,8,30]]},"assertion":[{"value":"28 June 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 August 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 August 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}